NOD2 regulates hematopoietic cell function during graft-versus-host disease

Journal of Experimental Medicine

Volumn 206, Issue 10, 2009, Pages 2101-2110

  Penack, Olaf ^a,b   Smith, Odette M ^a   Cunningham Bussel, Amy ^c   Liu, Xin ^c   Rao, Uttam ^a   Yim, Nury ^a   Na, Il Kang ^a,b   Holland, Amanda M ^a,c   Ghosh, Arnab ^a   Lu, Sydney X ^a   Jenq, Robert R ^a   Liu, Chen ^d   Murphy, George F ^e   Brandl, Katharina ^a,f   Van Den Brink, Marcel R M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CARD15 PROTEIN, MOUSE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CHIMERA; COLITIS; CONTROLLED STUDY; DISEASE MODEL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC CELL; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE; ANIMAL; BAGG ALBINO MOUSE; BONE MARROW TRANSPLANTATION; CYTOLOGY; EXPERIMENTAL NEOPLASM; GENETICS; HEMATOPOIETIC SYSTEM; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; NONOBESE DIABETIC MOUSE; PHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; ANTIGEN-PRESENTING CELLS; BONE MARROW TRANSPLANTATION; COLITIS; GRAFT VS HOST DISEASE; HEMATOPOIETIC SYSTEM; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; NEOPLASMS, EXPERIMENTAL; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 70350451119     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20090623     Document Type: Article

References (29)

1. Alpdogan, O., S.J. Muriglan, J.M. Eng, L.M. Willis, A.S. Greenberg, B.J. Kappel, and M.R. Van Den Brink. 2003. IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation. J. Clin. Invest. 112:1095-1107.
2. Bertin, J., W.J. Nir, C.M. Fischer, O.V. Tayber, P.R. Errada, J.R. Grant, J.J. Keilty, M.L. Gosselin, K.E. Robison, G.H. Wong, et al. 1999. Human CARD4 protein is a novel CED-4/Apaf-1 cell death family member that activates NF-kappaB. J. Biol. Chem. 274:12955-12958. doi:10.1074/jbc.274.19.12955
3. Caron, G., D. Duluc, I. Fremaux, P. Jeannin, C. David, H. Gascan, and Y. Delneste. 2005. Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+ T cells. J. Immunol. 175:1551-1557.
4. Dabbagh, K., and D.B. Lewis. 2003. Toll-like receptors and T-helper-1/T-helper-2 responses. Curr. Opin. Infect. Dis. 16:199-204.
5. Elmaagacli, A.H., M. Koldehoff, H. Hindahl, N.K. Steckel, R. Trenschel, R. Peceny, H. Ottinger, P.M. Rath, R.S. Ross, M. Roggendorf, et al. 2006. Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation. Transplantation. 81:247-254. doi:10.1097/01.tp.0000188671.94646.16
6. Hollander, G.A., B. Widmer, and S.J. Burakoff. 1994. Loss of normal thymic repertoire selection and persistence of autoreactive T cells in graft vs host disease. J. Immunol. 152:1609-1617.
7. Holler, E., G. Rogler, H. Herfarth, J. Brenmoehl, P.J. Wild, J. Hahn, G. Eissner, J. Scholmerich, and R. Andreesen. 2004. Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. Blood. 104:889-894. doi:10.1182/blood-2003-10-3543
8. Holler, E., G. Rogler, J. Brenmoehl, J. Hahn, H. Herfarth, H. Greinix, A.M. Dickinson, G. Socie, D. Wolff, G. Fischer, et al. 2006. Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination. Blood. 107:4189-4193. doi:10.1182/blood-2005-09-3741
9. Holler, E., J. Hahn, R. Andreesen, G. Rogler, J. Brenmoehl, H. Greinix, A.M. Dickinson, G. Socie, D. Wolff, and J. Finke. 2008. NOD2/CARD15 polymorphisms in allogeneic stem-cell transplantation from unrelated donors: T depletion matters. J. Clin. Oncol. 26:338-339. doi:10.1200/JCO.2007.14. 1325
10. Hugot, J.P., M. Chamaillard, H. Zouali, S. Lesage, J.P. Cezard, J. Belaiche, S. Almer, C. Tysk, C.A. O'Morain, M. Gassull, et al. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 411:599-603. doi:10.1038/35079107
11. Inohara, N., and G. Nunez. 2003. NODs: intracellular proteins involved in inflammation and apoptosis. Nat. Rev. Immunol. 3:371-382. doi:10.1038/nri1086
12. Inohara, N., Y. Ogura, F.F. Chen, A. Muto, and G. Nunez. 2001. Human Nod1 confers responsiveness to bacterial lipopolysaccharides. J. Biol. Chem. 276:2551-2554. doi:10.1074/jbc.M009728200
13. Kanazawa, N., I. Okafuji, N. Kambe, R. Nishikomori, M. Nakata-Hizume, S. Nagai, A. Fuji, T. Yuasa, A. Manki, Y. Sakurai, et al. 2005. Earlyonset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood. 105:1195-1197. doi:10.1182/blood-2004-07-2972
14. Kobayashi, K.S., M. Chamaillard, Y. Ogura, O. Henegariu, N. Inohara, G. Nunez, and R.A. Flavell. 2005. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science. 307:731-734. doi:10.1126/science.1104911
15. MacLeod, H., and L.M. Wetzler. 2007. T cell activation by TLRs: a role for TLRs in the adaptive immune response. Sci. STKE. 2007:pe48. doi:10.1126/stke.4022007pe48
16. Maeda, S., L.C. Hsu, H. Liu, L.A. Bankston, M. Iimura, M.F. Kagnoff, L. Eckmann, and M. Karin. 2005. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science. 307:734-738. doi:10.1126/science.1103685
17. Mayor, N.P., B.E. Shaw, D.A. Hughes, H. Maldonado-Torres, J.A. Madrigal, S. Keshav, and S.G. Marsh. 2007. Single nucleotide polymorphisms in the NOD2/CARD15 gene are associated with an increased risk of relapse and death for patients with acute leukemia after hematopoietic stem-cell transplantation with unrelated donors. J. Clin. Oncol. 25:4262-4269. doi:10.1200/JCO.2007.12. 1897
18. Miceli-Richard, C., S. Lesage, M. Rybojad, A.M. Prieur, S. Manouvrier-Hanu, R. Hafner, M. Chamaillard, H. Zouali, G. Thomas, and J.P. Hugot. 2001. CARD15 mutations in Blau syndrome. Nat. Genet. 29:19-20. doi:10.1038/ng720
19. Ogura, Y., D.K. Bonen, N. Inohara, D.L. Nicolae, F.F. Chen, R. Ramos, H. Britton, T. Moran, R. Karaliuskas, R.H. Duerr, et al. 2001. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 411:603-606. doi:10.1038/35079114
20. Scheiffele, F., and I.J. Fuss. 2002. Induction of TNBS colitis in mice. Curr. Protoc. Immunol. Chapter 15: Unit 15.19.
21. Strober, W., P.J. Murray, A. Kitani, and T. Watanabe. 2006. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat. Rev. Immunol. 6:9-20. doi:10.1038/nri1747
22. Terwey, T.H., T.D. Kim, A.A. Kochman, V.M. Hubbard, S. Lu, J.L. Zakrzewski, T. Ramirez-Montagut, J.M. Eng, S.J. Muriglan, G. Heller, et al. 2005. CCR2 is required for CD8-induced graft-versus-host disease. Blood. 106:3322-3330. doi:10.1182/blood-2005-05-1860
23. van Heel, D.A., S. Ghosh, M. Butler, K.A. Hunt, A.M. Lundberg, T. Ahmad, D.P. Mcgovern, C. Onnie, K. Negoro, S. Goldthorpe, et al. 2005. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease. Lancet. 365:1794-1796. doi:10.1016/S0140-6736(05)66582-8
24. Watanabe, T., A. Kitani, P.J. Murray, and W. Strober. 2004. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat. Immunol. 5:800-808. doi:10.1038/ni1092
25. Watanabe, T., A. Kitani, P.J. Murray, Y. Wakatsuki, I.J. Fuss, and W. Strober. 2006. Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis. Immunity. 25:473-485. doi:10.1016/j.immuni.2006.06.018
26. Watanabe, T., N. Asano, P.J. Murray, K. Ozato, P. Tailor, I.J. Fuss, A. Kitani, and W. Strober. 2008. Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. J. Clin. Invest. 118:545-559.
27. Yang, Z., I.J. Fuss, T. Watanabe, N. Asano, M.P. Davey, J.T. Rosenbaum, W. Strober, and A. Kitani. 2007. NOD2 transgenic mice exhibit enhanced MDP-mediated down-regulation of TLR2 responses and resistance to colitis induction. Gastroenterology. 133:1510-1521. doi:10.1053/j.gastro.2007.07. 025
28. Zakrzewski, J.L., A.A. Kochman, S.X. Lu, T.H. Terwey, T.D. Kim, V.M. Hubbard, S.J. Muriglan, D. Suh, O.M. Smith, J. Grubin, et al. 2006. Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation. Nat. Med. 12:1039-1047. doi:10.1038/nm1463
29. Zakrzewski, J.L., D. Suh, J.C. Markley, O.M. Smith, C. King, G.L. Goldberg, R. Jenq, A.M. Holland, J. Grubin, J. Cabrera-Perez, et al. 2008. Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors. Nat. Biotechnol. 26:453-461. doi:10.1038/nbt1395